Manténgase sano!

In a finding that suggests sooner is better than later, a new trial shows that giving advanced treatment early to Crohn's patients can dramatically improve their gut health.

About 80% of those who got therapy with an immune-suppressing drug called infliximab shortly after their Crohn's diagnosis experienced an improvement in their symptoms and inflammatory markers related to the disease, ...

Toddlers are famously picky eaters, but parents may be doing their young child's future gut a huge favor if they insist on a healthy diet.

New research shows that toddlers who eat plenty of fish and vegetables, and precious few sugary drinks, are less likely to develop inflammatory bowel disease (IBD) by the time they are teenagers. IBD includes conditions such as Crohn's disease and ulce...

Crohn's disease and ulcerative colitis show different patterns of incidence by race, gender and even place of birth, a new U.S. study finds.

The two illnesses are each classified as an inflammatory bowel disorder (IBD) -- conditions that trigger a chronic inflammation of the gastrointestinal tract.

The new research, from Rutgers University and other centers, found IBDs vary widely, ...

In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report.

Conditions such as alopecia (hair loss), psoriasis, vitiligo (white skin patches), vasculitis (inflammation of blood vessels), Crohn's disease, ulcerative colitis, rheumatoid arthritis, adult-onset Still's disease (painful skin rash), Sjogren's syndrome (autoimmune disease...

Some medications may not treat inflammatory bowel disease (IBD) as effectively if patients carry a lot of excess belly fat, , new research shows. IBD includes illnesses such as Crohn's disease and ulcerative colitis.

Researchers say using the wrong anti-inflammatory drug for these patients could mean lower rates of remission.

"Even though biologic medications have significantly impr...

Having inflammatory bowel disease, or IBD, could mean having a higher long-term risk of stroke, according to a new study.

People with IBD are 13% more likely to have a stroke up to 25 years after their diagnosis than those without the condition, the researchers found. Their report was published June 14 in the journal Neurology.

"These results show that people with inflammat...

Crohn's disease can turn your life into a gastrointestinal nightmare, but there is hope.

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), more than half a million Americans have Crohn's diseas...

Patients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).

Rinvoq is meant to treat adults with moderately to severely active Crohn's disease who have not had success with TNF (tumor necrosis factor) blockers. The daily pill is the first oral treatment for this group of patients.

Crohn's is ...

Crohn's disease, a type of inflammatory bowel disease, has no cure. But there are many treatments, specific to type, and it is possible to keep the symptoms under control.

A gastroenterologist offers some tips for those newly diagnosed with the condition.

"It's important to get a proper diagnosis and see an experienced inflammatory bowel disease (IBD) provider, preferably at a cent...

Overuse of antibiotics may trigger inflammatory bowel disease (IBD), new research suggests.

Among folks who were 40 or older, a new study found that antibiotics may increase the risk for bowel diseases, such as Crohn's and ulcerative colitis, for one to two years after use. And the greatest risk was posed by two classes of antibiotics -- nitroimidazoles and fluoroquinolones -- often used ...

Folks who follow a handful of healthy habits can dramatically reduce their risk of developing an inflammatory bowel disease, a new study reports.

Adopting and maintaining a healthy lifestyle can prevent up to 60% of cases of Crohn's disease and ulcerative colitis, according to research published Dec. 6 in the journal